Net sales and profits grew strongly year-over-year, with operating profit up 16.8% and net profit up 19.0%. The company forecasts continued growth for the full year, supported by a recent share split and robust segment performance.Original document: SHIMAMURA Co., Ltd. [8227] Interim report — Jun…
Record year with revenue up 14.3% and EBITDA up 91%, driven by focus on sexual health and own brands. Q4 saw 23.1% sales growth and a 10.9% EBITDA margin. Strong cash flow and balance sheet support a proposed 1.00 SEK per share dividend.Original document: Vuxen Group AB [VUXEN] Interim report — Jun…
EBITDA rose 343% to 6.2 MSEK and cash flow from operations improved by 14.9 MSEK, despite a 13% drop in net sales. Strategic investments in AI and efficiency drove record profitability, with the launch of the SolidMatch platform and expansion in the Nordics.Original document: SOLIDX AB [SOLIDX] Int…
The acquisition of Kayne Anderson Real Estate will add $22bn AuM, boosting the platform to $117bn and enhancing diversification, scale, and earnings quality. Management fee growth, strong fundraising momentum, and cross-sell opportunities are expected to drive significant EPS and EBITDA margin accr…
Double-digit growth in core EBITDA pre-SBP, adjusted EPS, and profit attributable to shareholders was achieved, with AUM rising 8% to £13.0bn. The group sharpened its focus on Real Assets and Private Equity, increased dividends and buybacks, and launched a new sustainability strategy.Original docum…
Revenue grew 1.3% year-over-year to £164.6m with gross margin up 1.7 points to 45.1%. Adjusted EBITDA rose to £24.7m, net debt fell to £8.6m, and a £9.8m impairment was recorded for Sequential. The outlook remains positive, with continued investment in innovation and direct-to-consumer channels.Ori…
Revenue grew 23% to £53.4m with recurring revenue at 81% and adjusted EBITDA up 28% to £14.5m. Strategic acquisitions, a robust cash position, and a share buyback programme supported growth, while risks include AI governance, competition, and cybersecurity.Original document: AdvancedAdvT Ltd. [ADVT…
TG4070, an individualized neoantigen vaccine, enters Phase 1 trial for resected NSCLC, leveraging proprietary AI-driven selection and scalable manufacturing. The myvacⓇ platform expands its reach, with TG4050 progressing in head and neck cancer and further technological advancements supporting broa…
Bridgepoint will acquire Kayne Anderson Real Estate for $1.393 billion, creating a $117 billion AUM platform spanning five asset classes. The deal is expected to be highly accretive to earnings, diversify income streams, and significantly expand US presence, with strong management continuity and sh…
Revenue grew 1.3% to £164.6m with adjusted EBITDA up 5.7% to £24.7m, driven by margin gains and cost control. Net debt fell to £8.6m, and a new proprietary silicon platform was launched. Both divisions contributed, with Content Creation up 3.6% OCC and Audio Reproduction stable.Original document: F…
Record H1 2026 revenue and profit were driven by strong growth in Metal Melt Quality and resilience in core markets, offsetting petrochemical weakness. Three acquisitions, including Drache and Carekem, strengthened all divisions. Full-year outlook remains positive, supported by a diversified portfo…
Adjusted profit before tax rose 11.7% to £6.0m and adjusted EPS increased 15.5% to 20.9p, driven by Project Genesis and operational improvements. Feed & Grain and Arable segments saw strong profit growth, while Stores faced margin pressure. Board expects full-year results in line with market expect…
Revenue surged 57% to US$9.7bn, with ecosystem aEBITDA up 84% and all operating companies aEBITDA-profitable. Major acquisitions, strong cash flow, and disciplined capital allocation supported growth, while AI integration and ecosystem synergies drove operational efficiency.Original document: Prosu…
FY25 saw strong revenue growth and commercial progress, with Tutivia test adoption accelerating and Medicare coverage secured. Cash runway extends to end-2026 after two equity raises, but further funding will be needed. Significant upside expected from new products and expanded market access.Origin…
Transitioned to mine development with a focus on antimony in Morocco and copper in Zambia, supported by a £2m equity raise. Net assets declined to £17.72m, with a net loss of £2.02m. Near-term production is expected at Amghas and Silverking, amid ongoing geopolitical and commodity price risks.Origi…
Revenue rose 23% to £53.4m, with recurring revenue at 81% and adjusted EBITDA up 28% to £14.5m. Three acquisitions expanded capabilities, while a share buyback returned £7.8m to shareholders. Strong cash generation and SaaS/cloud momentum support a positive outlook.Original document: AdvancedAdvT L…
Revenue grew 51% to US$10.8bn, with ecosystem aEBITDA up 84% and all core businesses aEBITDA-profitable. Major acquisitions and disciplined execution drove strong free cash flow and a 40% dividend increase, while AI innovation and ecosystem synergies remain strategic priorities.Original document: N…
Revenue surged 51% to US$10.8bn, driven by strong growth in LatAm, Europe, and India, and major acquisitions. Adjusted EBITDA rose 119% to US$1.1bn, while core headline earnings increased 14% to US$3.6bn. Strategic investments in AI and ecosystem expansion position the group for continued growth.Or…
Ecosystem revenue grew 12% to $9.7B, with aEBITDA up 44% and all segments profitable. Strong growth in LatAm, Europe, and India was supported by innovation, asset disposals, and a robust buyback program. Net debt remains low and investment grade ratings are maintained.Original document: Naspers Lim…
Ecosystem revenue grew 12% to $9.7B and aEBITDA rose 44% to $1.3B, with all segments profitable. Strong free cash flow, a robust balance sheet, and a $46B buyback highlight disciplined capital allocation and peer-leading growth across LatAm, India, and Europe.Original document: Prosus N.V. Class N…
